I do want to explore also—and maybe I'll go to Ms. Whattam for this—the moral dimension, because we talk about how the waiver isn't likely to spur vaccine production here in Canada, but in all fairness, I don't think that's ever really been the major claim that proponents of the waiver have been making. It's about world supply and it's about trying to address the current very real inequity in vaccine distribution globally by making more supply available and making it more available closer to places that aren't getting their fair share of the current vaccine supply.
I wonder if you could address a bit of that moral dimension for the committee.